-
24 July 2025 14:30:33
- Source: Sharecast

Tate & Lyle PLC
Result of Annual General Meeting 2025
Tate & Lyle PLC (the 'Company') announces that at its Annual General Meeting ('AGM') held earlier today, all resolutions contained in the Notice of Annual General Meeting 2025 issued on 3 June 2025 were duly passed.
The results of the poll held at the AGM are as follows:
Resolution |
Total For(1) |
Total Against |
Votes withheld(2) |
|||
No. of votes |
% of vote |
No. of votes |
% of vote |
No. of votes |
||
1. |
Report and Accounts |
346,214,388 |
99.99 |
41,754 |
0.01 |
207,544 |
2. |
Directors' Remuneration Policy |
335,249,944 |
97.75 |
7,732,103 |
2.25 |
3,481,639 |
3. |
Directors' Remuneration Report |
260,025,653 |
75.81 |
82,978,316 |
24.19 |
3,459,717 |
4. |
Approve final dividend |
344,289,578 |
99.99 |
33,635 |
0.01 |
2,140,473 |
5. |
Re-elect David Hearn |
323,314,691 |
93.91 |
20,983,235 |
6.09 |
2,165,760 |
6. |
Re-elect Nick Hampton |
340,517,246 |
98.90 |
3,773,478 |
1.10 |
2,172,962 |
7. |
Elect Sarah Kuijlaars |
342,249,202 |
99.41 |
2,039,926 |
0.59 |
2,174,558 |
8. |
Re-elect Jeffrey Carr |
334,912,242 |
97.27 |
9,389,327 |
2.73 |
2,162,117 |
9. |
Re-elect John Cheung |
335,322,858 |
97.39 |
8,979,711 |
2.61 |
2,161,117 |
10. |
Re-elect Dr Isabelle Esser |
291,493,971 |
85.98 |
47,526,592 |
14.02 |
7,443,123 |
11. |
Elect Glenn M.Fish |
340,809,705 |
98.99 |
3,484,366 |
1.01 |
2,169,615 |
12. |
Elect Steve Foots |
341,461,689 |
99.18 |
2,835,839 |
0.82 |
2,166,158 |
13. |
Re-elect Kimberly Nelson |
338,244,546 |
98.24 |
6,056,085 |
1.76 |
2,163,055 |
14. |
Re-elect Warren Tucker |
320,752,964 |
93.16 |
23,545,370 |
6.84 |
2,165,352 |
15. |
Elect Cláudia Vaz de Lestapis |
343,521,989 |
99.78 |
770,708 |
0.22 |
2,170,989 |
16. |
Re-appoint Ernst & Young LLP |
345,648,205 |
99.95 |
187,803 |
0.05 |
627,678 |
17. |
Approve auditors' remuneration |
346,246,882 |
99.95 |
185,847 |
0.05 |
30,957 |
18. |
Authority to make political donations |
344,895,608 |
99.56 |
1,507,509 |
0.44 |
60,569 |
19. |
Authority to allot ordinary shares |
311,532,415 |
89.93 |
34,899,632 |
10.07 |
31,639 |
20. |
Authority to disapply pre-emption rights |
324,621,321 |
93.72 |
21,746,841 |
6.28 |
95,524 |
21. |
Additional authority to disapply pre-emption rights for an acquisition or specified capital investment |
303,753,602 |
88.28 |
40,309,809 |
11.72 |
2,400,275 |
22. |
Authority to purchase own shares |
346,256,145 |
99.96 |
138,645 |
0.04 |
68,896 |
23. |
Authority in respect of shorter notices for general meetings |
335,675,209 |
96.90 |
10,751,308 |
3.10 |
36,737 |
While all Resolutions were passed, most with significant majorities in favour, the Board notes that 24.19% of the Shareholders voted against Resolution 3, which concerns the advisory vote on the Company's 2025 Directors' Remuneration Report. The Board has actively engaged with shareholders on remuneration in 2025 which has helped build a more detailed understanding of shareholder views and allowed the Board to provide context on the decisions made. We note that Resolution 2, which relates to the binding vote on the new Directors' Remuneration Policy, was approved by 97.75% of the Shareholders at the AGM. We will continue to engage and an update will be published within six months of today's Annual General Meeting, in accordance with the UK Corporate Governance Code.
(1) Includes discretionary votes.
(2) A 'vote withheld' is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.
On 22 July 2025 there were 476,739,802 ordinary shares in issue, with 31,294,579 ordinary shares held in treasury, so the total voting rights were 445,445,223.
In accordance with Listing Rule 9.6.2, copies of the resolutions passed as special business at the AGM will shortly be available to view via the National Storage Mechanism at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Matthew Joy
Company Secretary
24 July 2025
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.